zintick

Maze Therapeutics MAZE

Maze Therapeutics, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)

$31.73+0.13%close on Oct. 28, 2026 · volume 391K · Yahoo Finance

Price, last 47 sessions

$25.00$30.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $32.58 · low $22.39 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 1, 2026Jason Coloma V
Chief Executive Officer, director · indirect
Sold
10b5-1 plan
34,501$27.02
$27.02-$27.02
$932,260
Oct. 1, 2026Harold Bernstein
President, R&D & CMO
Sold
10b5-1 plan
16,141$26.93$434,743
Sept. 29, 2026Atul Dandekar
CSBO
Sold
10b5-1 plan
7,500$27.06$202,921
Sept. 4, 2026Harold Bernstein
President, R&D & CMO
Sold
10b5-1 plan
9,705$26.22$254,502
Sept. 3, 2026Phillips Courtney
GC and Corp. Secretary
Sold2,012$26.01
$25.78-$26.01
$52,334
Sept. 3, 2026Atul Dandekar
CSBO
Sold3,243$26.01
$25.81-$26.01
$84,354
Sept. 3, 2026Jason Coloma V
Chief Executive Officer, director
Sold11,411$26.01
$25.77-$26.01
$296,807
Sept. 3, 2026Harold Bernstein
President, R&D & CMO
Sold5,189$26.01
$25.78-$26.01
$134,969
Sept. 2, 2026Phillips Courtney
GC and Corp. Secretary
Sold1,981$26.47
$26.38-$27.12
$52,432
Sept. 2, 2026Atul Dandekar
CSBO
Sold3,191$26.47
$26.38-$27.12
$84,457
Sept. 2, 2026Jason Coloma V
Chief Executive Officer, director
Sold11,227$26.47
$26.38-$27.12
$297,148
Sept. 2, 2026Harold Bernstein
President, R&D & CMO
Sold5,106$26.47
$26.38-$27.12
$135,142

Latest 12 of 18. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 24 →